Assessing the Predictors of COVID-19 Vaccine Hesitancy Among People Living with HIV/AIDS: A Scoping Literature Review
Main Article Content
Abstract
Background: The administration of the COVID-19 vaccine at some points in the COVID-19 pandemic resulted in a significant reduction in the spread, risk of complications, and death from coronavirus infection. However, in the face of hesitancy against COVID-19 vaccination springing from the novelty of the vaccines and safety concerns, vulnerable population to COVID-19 infection such as people living with HIV/AIDS (PLWHA) were showing higher hesitancy to COVID-19 vaccines than the general population. This scoping review aims to identify factors COVID-19 vaccine hesitancy among people living with HIV/AIDS.
Methods: A scoping review was conducted to identify and summarize studies from all over the world on COVID-19 vaccine uptake/hesitancy among people living with HIV/AIDS.
The Preferred Reporting Items for Systematic Review and Meta-analysis (PRISMA) Extension for scoping reviews was used. Articles written in English, peer-reviewed, published within the years 2021-2023, and conducted in any part of the world with sample population being PLWHA, and with an outcome of uptake/hesitancy towards the COVID-19 vaccine were included.
Results: Fourteen articles met the inclusion criteria and were included in this review. The primary study settings were clinic and hospital-based and online self-reported. The prevalence of COVID-19 vaccine hesitancy was as high as 90.8% in an online survey done in the US and as low as 27.5% in a facility-based survey in China. The most common factors mentioned associated with COVID-19 vaccination were the fear of side effects of the COVID-19 vaccine, concerns about the safety of the vaccine, medical mistrust, vaccine novelty, disclosure of HIV status, and perceived interference with highly active antiretroviral therapy (HAART). Male gender, race, good knowledge of COVID-19 prevention practice, having a CD4 count > 200 cells (p=0.032) and lower or undetectable viral load (p<0.001) were identified as predictors of COVID-19 uptake.
Key findings: This wide margin in the prevalence of COVID-19 vaccine hesitancy between the US and China may be connected to the differences in the political climate, public perception and policies, and racial histories between the two countries. This review showed that those less willing to receive COVID-19 vaccination among people living with HIV/AIDS were those with high viral load and low CD4 count as they are more likely to have contact with healthcare system and more receptive of vaccination. Therefore, to limit the burden of COVID-19 vaccine hesitancy and the impact of COVID-19 disease among people living with HIV/AIDS, it is imperative for interventions to target people living with HIV/AIDS with suboptimal viral load and CD4 count (who are less likely to have contact with the healthcare system) as this predispose them to severe COVID-19 infection. A statistically significant association was found between COVID-19 vaccine hesitancy and black people living. So, it is important to address the root causes of negative perception and systemic racism experienced by the black race for steps to be made towards improving COVID-19 vaccine hesitancy and reducing the burden of disease among black people living with HIV/AIDS.
Article Details
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.
References
2. Alali WQ, Ali LA, AlSeaidan M, Al-Rashidi M. Effectiveness of BNT162b2 and ChAdOx1 Vaccines against Symptomatic COVID-19 among Healthcare Workers in Kuwait: A Retrospective Cohort Study. Healthcare. 2021;9(12):1692. doi:10.3390/healthcare9121692
3. Hulme WJ, Williamson EJ, Green ACA, et al. Comparative effectiveness of ChAdOx1 versus BNT162b2 covid-19 vaccines in health and social care workers in England: cohort study using OpenSAFELY. BMJ. 2022;378:e068946. doi:10.1136/bmj-2021-068946
4. Hildreth JEK, Alcendor DJ. Targeting COVID-19 Vaccine Hesitancy in Minority Populations in the US: Implications for Herd Immunity. Vaccines. 2021;9(5):489. doi:10.3390/vaccines9050489
5. MacDonald NE. Vaccine hesitancy: Definition, scope and determinants. Vaccine. 2015;33(34): 4161-4164. doi:10.1016/j.vaccine.2015.04.036
6. Ten health issues WHO will tackle this year. Accessed June 4, 2023.
https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-2019
7. Kimball S. How polio came back to New York for the first time in decades, silently spread and left a patient paralyzed. CNBC. Accessed October 10, 2022.
https://www.cnbc.com/2022/10/04/how-polio-silently-spread-in-new-york-and-left-a-person-paralyzed.html
8. Janz NK, Becker MH. The Health Belief Model: a decade later. Health Educ Q. 1984;11 (1):1-47. doi:10.1177/109019818401100101
9. Cummings PE, Lakoh S, Yendewa SA, et al. Understanding COVID-19 Vaccine Uptake and Hesitancy Among People With HIV in Freetown, Sierra Leone: A Cross-Sectional Study. Public and Global Health; 2023.
doi:10.1101/2023.05.11.23289882
10. Jarolimova J, Yan J, Govere S, et al. Medical Mistrust and Stigma Associated with COVID-19 Among People Living with HIV in South Africa. AIDS Behav. 2021;25(12):3967-3977. doi:10.1007/s10461-021-03307-8
11. Bogart LM, Ojikutu BO, Tyagi K, et al. COVID-19 Related Medical Mistrust, Health Impacts, and Potential Vaccine Hesitancy Among Black Americans Living With HIV. J Acquir Immune Defic Syndr 1999. 2021;86(2):200-207. doi:10.1097/QAI.0000000000002570
12. Liu Y, Han J, Li X, et al. COVID-19 Vaccination in People Living with HIV (PLWH) in China: A Cross Sectional Study of Vaccine Hesitancy, Safety, and Immunogenicity. Vaccines. 2021;9(12):1458. doi:10.3390/vaccines9121458
13. Zhao H, Wang H, Li H, et al. Uptake and adverse reactions of COVID-19 vaccination among people living with HIV in China: a case–control study. Hum Vaccines Immunother. 2021;17(12): 4964-4970. doi:10.1080/21645515.2021.1991183
14. Mesfin Y, Argaw M, Geze S, Tefera BT. Factors Associated with Intention to Receive COVID-19 Vaccine Among HIV Positive Patients Attending ART Clinic in Southwest Ethiopia. Patient Prefer Adherence. 2021;Volume 15:2731-2738. doi:10.2147/PPA.S342801
15. Shrestha R, Meyer JP, Shenoi S, et al. COVID-19 Vaccine Hesitancy and Associated Factors among People with HIV in the United States: Findings from a National Survey. Vaccines. 2022;10(3):424. doi:10.3390/vaccines10030424
16. Tricco AC, Lillie E, Zarin W, et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Ann Intern Med. 2018; 169(7):467-473. doi:10.7326/M18-0850
17. Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev. 2021; 10:89. doi:10.1186/s13643-021-01626-4
18. Swendeman D, Norwood P, Saleska J, et al. Vaccine Attitudes and COVID-19 Vaccine Intentions and Prevention Behaviors among Young People At-Risk for and Living with HIV in Los Angeles and New Orleans. Vaccines. 2022;10(3):413. doi:10.3390/vaccines10030413
19. Vallée A, Fourn E, Majerholc C, Touche P, Zucman D. COVID-19 Vaccine Hesitancy among French People Living with HIV. Vaccines. 2021;9(4): 302. doi:10.3390/vaccines9040302
20. Kabir Sulaiman S, Sale Musa M, Isma’il Tsiga-Ahmed F, et al. COVID-19 vaccine hesitancy among people living with HIV in a low-resource setting: A multi-center study of prevalence, correlates and reasons. Vaccine. 2023;41(15):2476-2484. doi:10.1016/j.vaccine.2023.02.056
21. Shallangwa MM, Musa SS, Iwenya HC, Manirambona E, Lucero-Prisno Iii DE, Tukur BM. Assessment of COVID-19 vaccine hesitancy among people living with HIV/AIDS: a single-centered study. PAMJ - One Health. 2023;10. doi:10.11604/pamj-oh.2023.10.2.37945
22. Yao Y, Chai R, Yang J, et al. Reasons for COVID-19 Vaccine Hesitancy Among Chinese People Living With HIV/AIDS: Structural Equation Modeling Analysis. JMIR Public Health Surveill. 2022;8(6):e33995. doi:10.2196/33995
23. Qi L, Yang L, Ge J, Yu L, Li X. COVID-19 Vaccination Behavior of People Living with HIV: The Mediating Role of Perceived Risk and Vaccination Intention. Vaccines. 2021;9(11):1288. doi:10.3390/vaccines9111288
24. Huang X, Yu M, Fu G, et al. Willingness to Receive COVID-19 Vaccination Among People Living With HIV and AIDS in China: Nationwide Cross-sectional Online Survey. JMIR Public Health Surveill. 2021;7(10):e31125. doi:10.2196/31125
25. Menza TW, Capizzi J, Zlot AI, Barber M, Bush L. COVID-19 Vaccine Uptake Among People Living with HIV. AIDS Behav. 2022;26(7):2224-2228. doi:10.1007/s10461-021-03570-9
26. Wickersham JA, Meyer JP, Shenoi S, et al. Willingness to Be Vaccinated Against COVID-19 Among People With HIV in the United States: Results From a National Survey. Front Med. 2022;9:88 6936. doi:10.3389/fmed.2022.886936
27. Krause KD, Pérez-Figueroa RE, Halkitis PN. Barriers and facilitators related to COVID-19 vaccine acceptance and uptake among people living with HIV. Curr Opin HIV AIDS. 2023;18(3):142-147. doi:10.1097/COH.0000000000000788
28. Leong C, Jin L, Kim D, Kim J, Teo YY, Ho TH. Assessing the impact of novelty and conformity on hesitancy towards COVID-19 vaccines using mRNA technology. Commun Med. 2022;2(1):1-6. doi:10.1038/s43856-022-00123-6
29. Mello MM. Vaccine Misinformation and the First Amendment—The Price of Free Speech. JAMA Health Forum. 2022;3(3):e220732. doi:10.1001/jamahealthforum.2022.0732
30. Greer SL, King EJ, Massard Da Fonseca E, Peralta-Santos A. Coronavirus Politics: The Comparative Politics and Policy of COVID-19. University of Michigan Press; 2021. doi:10.3998/mpub.11927713
31. Enos O. Holding the Chinese Communist Party Accountable for Its Response to the COVID-19 Outbreak. (5074).
32. Shih V. China’s Leninist response to COVID-19. Coronavirus Polit. Published online 2021:67-85.
33. Salinas-Escudero G, Carrillo-Vega MF, Granados-García V, Martínez-Valverde S, Toledano-Toledano F, Garduño-Espinosa J. A survival analysis of COVID-19 in the Mexican population. BMC Public Health. 2020;20(1):1616. doi:10.1186/s12889-020-09721-2
34. Bhaskaran K, Rentsch CT, MacKenna B, et al. HIV infection and COVID-19 death: a population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform. Lancet HIV. 2021; 8(1):e24-e32. doi:10.1016/S2352-3018(20)30305-2
35. Yendewa GA, Perez JA, Schlick K, Tribout H, McComsey GA. Clinical Features and Outcomes of Coronavirus Disease 2019 Among People With Human Immunodeficiency Virus in the United States: A Multicenter Study From a Large Global Health Research Network (TriNetX). Open Forum Infect Dis. 2021;8(7):ofab272.
doi:10.1093/ofid/ofab272
36. Coronavirus disease (COVID-19) and people living with HIV. Accessed June 4, 2023. https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-(covid-19)-covid-19-and-people-living-with-hiv
37. Aita M, Richer MC. Essentials of research ethics for healthcare professionals. Nurs Health Sci. 2005;7(2):119-125. doi:10.1111/j.1442-2018.2005.00216.x
38. Shui I, Kennedy A, Wooten K, Schwartz B, Gust D. Factors influencing African-American mothers’ concerns about immunization safety: a summary of focus group findings. J Natl Med Assoc. 2005;97(5):657-666.
39. Gamble VN. Under the shadow of Tuskegee: African Americans and health care. Am J Public Health. 1997;87(11):1773-1778. doi:10.2105/AJPH.87.11.1773
40. Adebimpe VR. Race, Racism, and Epidemiological Surveys. Psychiatr Serv. 1994;45 (1):27-31. doi:10.1176/ps.45.1.27
41. Swanson RC, Cattaneo A, Bradley E, et al. Rethinking health systems strengthening: key systems thinking tools and strategies for transformational change. Health Policy Plan. 2012;27(suppl 4):iv54-iv61. doi:10.1093/heapol/czs090
42. Price-Haywood EG, Burton J, Fort D, Seoane L. Hospitalization and Mortality among Black Patients and White Patients with Covid-19. N Engl J Med. 2020;382(26):2534-2543. doi:10.1056/NEJMsa2011686
43. Abrams EM, Szefler SJ. COVID-19 and the impact of social determinants of health. Lancet Respir Med. 2020;8(7):659-661. doi:10.1016/S2213-2600(20)30234-4
44. Shiau S, Krause KD, Valera P, Swaminathan S, Halkitis PN. The Burden of COVID-19 in People Living with HIV: A Syndemic Perspective. AIDS Behav. 2020;24(8):2244-2249. doi:10.1007/s10461-020-02871-9
45. Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Moderna COVID-19 Vaccine — United States, December 21, 2020–January 10, 2021. MMWR Morb Mortal Wkly Rep. 2021;70. doi:10.15585/mmwr.mm7004e1
46. https://www.washingtonexaminer.com/author/daniel-nuccio. CDC repeatedly spread COVID misinformation, researchers say. Restoring America. Published April 14, 2023. Accessed July 4, 2023. https://www.washingtonexaminer.com/restoring-america/fairness-justice/cdc-repeatedly-spread-covid-misinformation-researchers-say
47. Walensky RP. Opinion | What I Need to Tell America Before I Leave the C.D.C. The New York Times. https://www.nytimes.com/2023/06/27/opinion/rochelle-walensky-cdc-pandemic-despair.html. Published June 27, 2023. Accessed July 4, 2023.
48. Regazzi L, Lontano A, Cadeddu C, Di Padova P, Rosano A. Conspiracy beliefs, COVID-19 vaccine uptake and adherence to public health interventions during the pandemic in Europe. Eur J Public Health. Published online June 8, 2023: ckad089. doi:10.1093/eurpub/ckad089
49. Gurol-Urganci I, de Jongh T, Vodopivec-Jamsek V, Atun R, Car J. Mobile phone messaging reminders for attendance at healthcare appointments. Cochrane Database Syst Rev. 2013;2013(12): CD007458. doi:10.1002/14651858.CD007458.pub3